Healthcare - Medical - Devices - NYSE - US
$ 18.68
-2.45 %
$ 858 M
Market Cap
39.74
P/E
CASH FLOW STATEMENT
32.4 M
OPERATING CASH FLOW
21.6 M
INVESTING CASH FLOW
-94.2 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Avanos Medical, Inc.
| Net Income | -61.8 M |
| Depreciation & Amortization | 46.1 M |
| Capital Expenditures | -17.8 M |
| Stock-Based Compensation | 15.8 M |
| Change in Working Capital | -18 M |
| Others | 3 M |
| Free Cash Flow | 14.6 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | Dec-2013 | Dec-2012 | Dec-2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | |||||||||||||
| Net Income | (61.8) | 50.5 | 5.2 | (27.2) | (45.9) | 57.5 | 79.3 | 39.8 | (426.3) | 27.1 | 154.6 | 152.6 | 142.4 |
| Depreciation & Amortization | 46.1 | 47.7 | 38.3 | 42.9 | 36.9 | 33.5 | 59.5 | 65.2 | 65.4 | 85.4 | 69.2 | 57.6 | 51.1 |
| Deferred Income Tax | 0 | 0 | (3.4) | 25.9 | (6.5) | 3.7 | (6.2) | (11.5) | 8.2 | (35.0) | (0.9) | (11.6) | 3.5 |
| Stock Based Compensation | 15.8 | 15.9 | 13.2 | 12.1 | 10.5 | 10.5 | 12.6 | 14.8 | 14.1 | 7.9 | 6.0 | 5.3 | 2.6 |
| Other Operating Activities | 50.3 | 1.1 | 8.0 | 11.6 | (9.9) | (107.4) | 3.3 | (11.1) | 453.2 | 49.7 | 6.8 | (10.9) | 8.3 |
| Change in Working Capital | (18.0) | (24.3) | 26.0 | (67.8) | (59.6) | (143.4) | (4.3) | 91.6 | (17.0) | 12.8 | (11.9) | 9.6 | (68.3) |
| Cash From Operations | 32.4 | 90.9 | 87.3 | (2.5) | (74.5) | (145.6) | 144.2 | 188.8 | 97.6 | 147.9 | 223.8 | 202.6 | 139.6 |
| INVESTING CASH FLOW | |||||||||||||
| Capital Expenditures | (17.8) | (19.3) | (21.0) | (20.2) | (50.6) | (49.1) | (43.2) | (29.1) | (70.4) | (78.5) | (49.0) | (40.8) | (39.7) |
| Other Items | 39.4 | (116.1) | 0 | (4.0) | (57.5) | 688.6 | 100 K | (171.8) | 7.8 | 7.8 | (1.9) | 0.5 | 0.2 |
| Cash From Investing Activities | 21.6 | (135.4) | (21.0) | (24.2) | (108.1) | 639.5 | (43.1) | (200.9) | (62.6) | (70.7) | (50.9) | (40.3) | (39.5) |
| FINANCING CASH FLOW | |||||||||||||
| Common Stock Repurchased | (19.1) | (45.5) | (11.5) | (0.9) | (3.6) | (0.9) | (2.5) | (0.9) | (1.0) | 0 | 0 | 0 | 0 |
| Total Debt Repaid | (64.7) | 103.4 | (50.0) | (69.8) | (0.2) | (339.0) | 0 | (0.9) | (51.0) | 624.2 | (63.9) | (24.1) | 11.8 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (680.0) | 0 | 0 | 0 |
| Other Financing Activities | (10.4) | (1.2) | 6.2 | 0.7 | 5.3 | 15.5 | 4.7 | 0.4 | 1.4 | (595.0) | (116.1) | (109.8) | (126.9) |
| Cash From Financing Activities | (94.2) | 56.7 | (55.3) | (70.0) | 1.5 | (324.4) | 2.2 | (1.4) | (50.6) | 29.2 | (180.0) | (133.9) | (115.1) |
| CHANGE IN CASH | |||||||||||||
| Net Change In Cash | (40.0) | 9.2 | 7.0 | (93.8) | (179.2) | 164.8 | 106.0 | (15.8) | (19.5) | 104.9 | (3.8) | 27.8 | (14.2) |
| FREE CASH FLOW | |||||||||||||
| Free Cash Flow | 14.6 | 71.6 | 66.3 | (22.7) | (125.1) | (194.7) | 101.0 | 159.7 | 27.2 | 69.4 | 174.8 | 161.8 | 99.9 |